GTG
|
Genetic Technologies Limited
|
AU
|
ASX
|
HBIO
|
Harvard Bioscience, Inc.
|
US
|
NASDAQ
|
HVO
|
Hvivo Plc
|
UK
|
LSE
|
ICLR
|
ICON plc
|
US
|
NASDAQ
|
ILMN
|
Illumina, Inc.
|
US
|
NASDAQ
|
INIS
|
International Isotopes Inc
|
US
|
OTC
|
IQV
|
IQVIA Holdings, Inc.
|
US
|
NYSE
|
IXI
|
Ixico Plc
|
UK
|
LSE
|
LAXAF
|
Laxai Pharma Ltd
|
US
|
OTC
|
MEDP
|
Medpace Holdings, Inc.
|
US
|
NASDAQ
|
MEM
|
Memphasys Ltd
|
AU
|
ASX
|
MTD
|
Mettler-Toledo International, Inc.
|
US
|
NYSE
|
MTST
|
MetaStat Inc
|
US
|
US
|
NEO
|
NeoGenomics, Inc.
|
US
|
NASDAQ
|
NOTV
|
Inotiv, Inc.
|
US
|
NASDAQ
|
NSTG
|
NanoString Technologies, Inc.
|
US
|
NASDAQ
|
OBD
|
Oxford Biodynamics Plc
|
UK
|
LSE
|
OSL
|
Oncosil Medical Ltd
|
AU
|
ASX
|
PACB
|
Pacific Biosciences of California, Inc.
|
US
|
NASDAQ
|
PAIYY
|
Aesthetic Medical International Holdings Group Limited
|
US
|
US
|